First Psychedelic Drug Trial Firm Opens in London

First Psychedelic Drug Trial Firm Opens in London
High Times

In what is absolutely a sign that the new interest in psychedelic drugs has landed on the other side of The Pond, a new commercial facility has opened for trials in London. Clerkenwell Health, a British start-up, will begin trials of psilocybin to help terminal patients manage the anxiety caused by this kind of diagnosis starting in August. The intent is to support trial participants through the end of palliative care. The facility will be located near Harley Street—a famed address globally for attracting doctors and firms offering state-of-the-art medical treatments and therapies. The firm will be working in cooperation with North American firms in both Canada and the United States which focus on treatments for neurological and psychiatric disorders. The move is not unexpected and indeed is likely to be just the next step in a widely anticipated trend. Biotech firms of all kinds, including for psychedelics starting with cannabis, have been eyeing the U.K., post-Brexit, as a haven for this kind of experimental research. This is because Britain is no longer bound by the rules and regulations of the European Medicines Agency and other regulatory bodies necessary to approve such research on a regional basis. Beyond this, of course, other psychedelic drugs—and psilocybin in particular—are beginning to have a new renaissance in the research community globally. It is undeniable that this is due, in part, to cannabis reform. In many ways it is the ending of Prohibition globally, more than Brexit, which has opened these doors. Regardless, there is great interest now in exploring all kinds of psychedelic drugs to treat mental health conditions ranging from mood disorders and PTSD to addiction. The policies of the War on Drugs made research of all of them highly challenging. Getting both approvals and funding was next to impossible everywhere. Indeed,…

Excerpt only …
Source : First Psychedelic Drug Trial Firm Opens in London

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.